⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1921248 | 0.78 | ALDH1A1 (0.50) | — | |
| Ethylene SCHEMBL8561573 | 0.77 | ALDH1A1 (0.48) | — | |
| SCHEMBL2095291 | 0.76 | — | — | |
| SCHEMBL1016594 | 0.76 | — | — | |
| SCHEMBL2286535 | 0.76 | — | — | |
| SCHEMBL18660230 | 0.76 | ALDH1A1 (0.47) | — | |
| SCHEMBL1682671 | 0.76 | — | — | |
| SCHEMBL1015825 | 0.74 | — | — | |
| SCHEMBL305496 | 0.74 | ALDH1A1 (0.61) | — | |
| SCHEMBL21057919 | 0.74 | ALDH1A1 (0.45) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112007045-A | Chiral control | 波涛生命科学有限公司 | 2020-12-01 | — | — | CN | disclosed |
| CN-104661664-B | Chiral control | 波涛生命科学有限公司 | 2020-07-03 | — | — | CN | disclosed |
| CN-111050806-A | Oligonucleotide compositions and methods of use thereof | 波涛生命科学有限公司 | 2020-04-21 | — | — | CN | disclosed |
| EP-3016964-A1 | METHOD FOR INCORPORATING PROTECTING ACETAL AND ACETAL ESTER GROUPS, AND ITS APPLICATION FOR THE PROTECTION OF HYDROXYL FUNCTION | Instytut Chemii Bioorganicznej Polskiej Akademii Nauk (PL) | 2016-05-11 | — | — | EP | disclosed |
| WO-2014148928-A1 | METHOD FOR INCORPORATING PROTECTING ACETAL AND ACETAL ESTER GROUPS, AND ITS APPLICATION FOR THE PROTECTION OF HYDROXYL FUNCTION | INSTYTUT CHEMII BIOORGANICZNEJ POLSKIEJ AKADEMII NAUK (PL) | 2014-09-25 | — | — | WO | disclosed |